Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India

R. Kumar, N. Gupta, J. Mittal (Delhi, Dehi, India)

Source: International Congress 2014 – Intervening in allergic asthma
Session: Intervening in allergic asthma
Session type: Poster Discussion
Number: 3474
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Kumar, N. Gupta, J. Mittal (Delhi, Dehi, India). Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India. Eur Respir J 2014; 44: Suppl. 58, 3474

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Skin prick test versus specific IgE – A comparative study in patients with bronchial asthma and allergic rhinitis in India
Source: International Congress 2014 – Clinical allergy
Year: 2014

Therapeutic effectpredictors during sublingual immunotherapy for Japanese seasonal allergic rhinitis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

Comparative efficacy of different groups of drugs for the treatment of bronchial asthma in combination with allergic rhinitis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014

The impact of psychological distress on allergic rhinitis and asthma control
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Serum IL-10 and IL-17 are not related to the efficacy of allergen specific immunotherapy in asthma
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014

Predictors factors for asthma in patients with rhinitis
Source: International Congress 2014 – Clinical allergy
Year: 2014


Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


Distribution of mast cells and their interactions with nerve in allergic rhinitis
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab
Source: International Congress 2014 – More paediatric asthma
Year: 2014

Influence of maternal bronchial asthma clinical phenotype on development of allergies in children
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014

Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma whether due to seasonal allergens or to perennial allergens
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

Fungal sensitization in patients with moderate and severe asthma
Source: International Congress 2014 – Clinical allergy
Year: 2014


The impact of sublingual allergen-specific therapy on asthma control and quality of life
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Tolerability and adherence to sublingual immunotherapy with mite vaccines with different schedule in asthmatic children
Source: International Congress 2014 – More paediatric asthma
Year: 2014

Allergic rhinitis does it have an impact on controller asthma therapy choice
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014


25(OH) vitamin D levels in pediatric asthma and allergic rhinitis
Source: International Congress 2014 – More paediatric asthma
Year: 2014


QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014


Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015